Status:
COMPLETED
Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study
Lead Sponsor:
Stanford University
Conditions:
Coagulopathy
Eligibility:
All Genders
Up to 8 years
Brief Summary
Congenital heart surgery on cardio-pulmonary bypass (CPB) is associated with impacted coagulation quality and increased bleeding after separation of CPB. The current testing device used at our instit...
Detailed Description
Congenital heart surgery on cardio-pulmonary bypass (CPB) is associated with impacted coagulation quality and increased bleeding after separation of CPB. Therefore, coagulation products and blood prod...
Eligibility Criteria
Inclusion
- All cases with hypothermia (\<=30C)
Exclusion
- Neonatal/Infant Bloodless surgery
- Bodyweight under 3kg
Key Trial Info
Start Date :
October 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 25 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05295693
Start Date
October 13 2022
End Date
May 25 2023
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305